Suppr超能文献

主要人参皂苷Rb(1)向具有药学活性的次要人参皂苷Rd的微生物转化

Microbial conversion of major ginsenoside rb(1) to pharmaceutically active minor ginsenoside rd.

作者信息

Kim Myung Kyum, Lee Jun Won, Lee Ki Young, Yang Deok-Chun

机构信息

Department of Oriental Medicinal Material & Processing, College of Life science, Kyung Hee University, Yongin, Kyunggi-do 449-701, Republic of Korea.

出版信息

J Microbiol. 2005 Oct;43(5):456-62.

Abstract

More than seventy strains of aerobic bacteria showing beta-glucosidase activity were isolated from a ginseng field, using a newly designed Esculin-R2A agar, and identified by their 16S rRNA gene sequences. Of these microorganisms, twelve strains could convert the major ginsenoside, Rb(1), to the pharmaceutically active minor ginsenoside Rd. Three strains, Burkholderia pyrrocinia GP16, Bacillus megaterium GP27 and Sphingomonas echinoides GP50, were phylogenetically studied, and observed to be most potent at converting ginsenoside Rb(1) almost completely within 48 h, as shown by TLC and HPLC analyses.

摘要

使用新设计的七叶苷-R2A琼脂,从人参田中分离出70多种具有β-葡萄糖苷酶活性的需氧细菌菌株,并通过其16S rRNA基因序列进行鉴定。在这些微生物中,有12个菌株可将主要人参皂苷Rb(1)转化为具有药理活性的次要人参皂苷Rd。对伯克霍尔德氏菌GP16、巨大芽孢杆菌GP27和棘状鞘氨醇单胞菌GP50这三个菌株进行了系统发育研究,通过薄层色谱(TLC)和高效液相色谱(HPLC)分析表明,它们在48小时内将人参皂苷Rb(1)几乎完全转化的能力最强。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验